MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Han Yang1,2, Yufang Liu1,2, Longqing Chen1,2

  • 1Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.

Biomolecules
|June 28, 2023
PubMed

Insights

MicroRNAs (miRNAs) show promise in treating lung cancer, complementing existing therapies and reversing drug resistance. miRNA-based treatments are advancing into clinical trials for improved lung cancer patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer deaths globally.
  • Advanced lung cancer prognosis remains poor despite recent therapeutic advancements.
  • MicroRNAs (miRNAs) play a crucial role in regulating tumor development.

Purpose of the Study:

  • To review recent advances in microRNA (miRNA)-based therapies for lung cancer.
  • To discuss the current state of clinical lung cancer treatment.
  • To explore the potential of miRNA-based therapies as adjuvant treatments and to overcome drug resistance.

Main Methods:

  • Review of current literature on miRNA-based therapies in lung cancer.
  • Analysis of preclinical and clinical trial data for miRNA and small interfering RNA (siRNA) therapies.
  • Discussion of challenges and future directions for miRNA-based lung cancer treatment.

Main Results:

  • miRNA mimics and regulatory molecules show preclinical promise.
  • miRNA-based therapies can enhance conventional treatments, reversing drug resistance.
  • Small interfering RNA (siRNA) and miRNA therapies are progressing favorably in clinical trials.

Conclusions:

  • miRNA-based therapies offer a promising avenue for lung cancer treatment and adjuvant therapy.
  • These therapies have the potential to improve sensitivity and overcome resistance in lung cancer cells.
  • Further research and clinical application are needed to address challenges and develop novel lung cancer therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
68